Development and production of parenteral dosage forms for clinical studies; 09/20/2013-09/19/2018: task order for kick-off webinar

Ended Awarded Last action

Contract number
HHSN26100001
Awardee
Awarding agency
Obligated
$1,000

Award facts

Opportunity
Contract value 100% obligated
$1,000.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
B504 Special Studies/Analysis- Chemical/Biological
Set-aside
Partial Small Business
Competition
Full and Open Competition after exclusion of sources · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
San Diego, CA 92121, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action 1 $0
Original award $1,000

Quick answers

Who was awarded contract HHSN26100001?

HHSN26100001 was awarded to Eurofins Advantar Laboratories, LLC by National Cancer Institute (National Institutes of Health) on September 20, 2013.

How much is contract HHSN26100001 worth?

The government has obligated $1,000 on HHSN26100001.

Is contract HHSN26100001 an order under another contract?

Yes. HHSN26100001 is a delivery order under HHSN261201300033I, an indefinite delivery contract, on Parenteral Dosage Forms for Clinical Studies.

Was contract HHSN26100001 competed?

The extent of competition for HHSN26100001 was full and open competition after exclusion of sources. The government received 1 offer. It was set aside: Partial Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login